Amgen's Repatha reduces first-time heart attack and stroke risk by 25%
Originally Published 2 months ago — by statnews.com
A study published in the New England Journal of Medicine shows that Amgen's cholesterol injection Repatha significantly reduces the risk of heart attacks, strokes, and cardiovascular death in high-risk individuals without prior events, outperforming traditional statin therapy.
